Published 1 year ago • loading... • Updated 1 year ago

CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans

Summary by CNBC

Starting July 1, Caremark will prioritize Wegovy on its formulary, making the weekly injection more accessible to its members.

8 Articles

Politiken

Lean Left

Novo Nordisk has come a step closer to Wegovy in pill form in the US

The US FDA has accepted an application to potentially sell oral Wegovy as a pill in the US.

1 year ago·Copenhagen, Denmark

Read Full Article

STAT

Center

Eli Lilly shares fall as competitor Novo notches coverage win for obesity drug

Novo reached a coverage deal with CVS Caremark, giving its obesity drug Wegovy a boost as it competes against Lilly's Zepbound

1 year ago·Boston, United States

Read Full Article

Lean Left

Novo shares rise after major deal with US company

Novo Nordisk has entered into an agreement with CVS Caremark to expand access to Wegovy from July 1. Novo Nordisk writes in a press release.

1 year ago·Copenhagen, Denmark

Read Full Article

washingtonstatestandard.com

Left

Biden wanted Medicaid to pay for weight-loss drugs. Trump just said it doesn’t have to. • Washington State Standard

In this photo illustration, the injectable weight-loss medication Wegovy is available at a Chicago pharmacy last year. The Biden administration proposed a rule that would have required state Medicaid programs to cover GLP-1s for obesity treatment, but the Trump administration said it will leave the option up to the states. (Photo illustration by Scott Olson/Getty Images)The Trump administration this month scrapped a Biden-era proposal that would…

1 year ago

Read Full Article